Belgium · pharma corridor
Pharmaceutical Cold Storage and Warehouse Cooling in Belgium
Belgium combines large-scale biologics and vaccine manufacturing with one of the world's densest air-freight pharma corridors. The result is a market where both deep validated storage and fast-turnaround handling capacity are procured — often on the same site — and where ULT capability is more common than country size suggests.
Direct answers for project buyers
Pharmaceutical cold storage in Belgium is planned around a roughly 30–32 °C summer design condition, a mature validated-storage supplier base, and two distinct project types: manufacturer and CDMO storage attached to biologics production (including significant ULT demand), and airport-linked handling facilities where turnaround speed and excursion control dominate the design.
The market in context
Planning parameters
- Summer ambient design
- ≈ 30–32 °C dry bulb
- Electricity (commercial, indicative)
- ≈ EUR 0.16–0.28 / kWh
- Typical bands
- +15/+25 °C CRT, +2/+8 °C, −20 °C, −70/−80 °C ULT (well represented)
- Second project type
- Airport-linked handling and staging with rapid turnaround
- Redundancy norm
- N+1 minimum; 2N and backup injection common on ULT
- Procurement note
- Dutch / French / English — fix one specification language
Direct answers for project buyers
How is a mixed +2/+8 °C and ULT facility planned?
Treat them as separate systems that share a building, not as one plant with different setpoints. ULT needs cascade or two-stage plant, its own backup strategy (spare units or backup injection), its own monitoring and its own plant-room condition. Sharing condensing capacity across bands to save money usually costs more in complexity and risk than it saves.
What belongs in a Belgian pharma RFQ that is often left out?
Transfer and excursion procedures, the interface between refrigeration scope and building scope, monitoring continuity across handovers, and the service response commitment with a stated response time. These are the items that decide whether the facility actually performs after handover.
Manufacturer storage or contracted GDP capacity?
Contracted capacity suits variable and short-horizon volume, especially for ULT where investment per litre is high. Owned storage suits stable volume and product that must stay under direct control. Compare on cost per pallet position per year including validation and monitoring, not on CAPEX alone.
Typical project scale
- CDMO or manufacturer suite: 100–800 m² multi-band
- Distribution and staging facility: 800–5,000 m²
- Biologics campus: dedicated ULT zone plus chilled and frozen areas
How this project is usually structured
- 1Belgium
- 2Biologics manufacturer / airport-linked handling facility
- 3+2/+8 °C and −70/−80 °C ULT zones
- 4Separate plant per band, N+1 with backup injection
- 5Cooling load → redundancy planner → TCO
- 6Structured pharmaceutical RFQ
Tools for this project
How ColdMatch Group works — independent B2B procurement and sourcing platform — ColdMatch Group is an independent B2B procurement and sourcing platform for industrial refrigeration, cold storage and cold-chain projects from USD $250K+, connecting buyers with qualified third-party suppliers, EPC contractors and independent financing providers.
References
ColdMatch Group is a B2B procurement platform. It provides planning tools and connects project buyers with relevant manufacturers and solution providers. It is not a manufacturer, engineering contractor, validation consultant or certification body, and nothing on this page is regulatory or validation advice.